Risk Factors Update Summary
- Addition of risk related to competition from largest customers may reduce orders, impacting revenues.
- Issuance of $600 million in aggregate principal amount of 1.00% Convertible Senior Notes due 2028.
- Acquisition of Metenova Holding AB and FlexBiosys, Inc. poses operational and accounting risks.
- Identified material weakness in internal controls over financial reporting related to accounting for notes exchange.
- Potential adverse impact from physical risks of climate change on manufacturing and supply chain.
- Ongoing litigation challenging constitutionality of Medicare drug price negotiation program may affect business.
- Evolving and uncertain privacy standards, including CPRA, impose additional obligations and potential costs.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=730272&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.